Short Interest in Arcadia Biosciences, Inc. (NASDAQ:RKDA) Expands By 297.4%

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totaling 6,339 shares, an increase of 297.4% from the April 15th total of 1,595 shares. Based on an average daily volume of 39,192 shares, the short-interest ratio is presently 0.2 days. Approximately 0.3% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Arcadia Biosciences from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Arcadia Biosciences Price Performance

RKDA stock remained flat at $1.06 during trading on Wednesday. 29,205 shares of the company traded hands, compared to its average volume of 33,129. The company has a market capitalization of $2.18 million, a price-to-earnings ratio of -0.62 and a beta of 0.52. The firm has a fifty day moving average price of $1.42 and a 200 day moving average price of $2.35. Arcadia Biosciences has a 1-year low of $0.89 and a 1-year high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last posted its quarterly earnings data on Thursday, March 26th. The basic materials company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.66) by ($0.32). The company had revenue of $0.90 million during the quarter, compared to analyst estimates of $1.40 million. Arcadia Biosciences had a positive return on equity of 37.36% and a negative net margin of 48.15%.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.